The recent rise for Catalent can be attributed to reports of Danaher looking to acquire the company. Catalent’s revenue growth over the recent years was primarily driven by robust demand for its ...

SEE RELATED STORY: 'Ultimately, this intervention is necessary': State announces official TEA takeover of Houston ISD But before anything becomes official, there are plenty of questions left for ...

So I found the recent news that Danaher is interested in acquiring contract manufacturer Catalent, Inc. (CTLT) quite interesting. Putting myself in the shoes of an investor who plans to buy shares ...

Houston is the largest school district in Texas and the eighth largest in the U.S. While the state of Texas claims the planned takeover is about school improvement, my research on state takeovers ...

Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity.

Catalent, Inc. CTLT recently announced its successful formulation design and clinical-phase manufacturing collaboration with Grünenthal for an orally dosed small molecule in the latter’s pipeline.

In the latest trading session, Danaher (DHR) closed at $242.11, marking a -1.12% move from the previous day. This move lagged the S&P 500's daily loss of 0.7%. Meanwhile, the Dow lost 0.87% ...

UKRAINE - 2021/05/04: In this Photo illustration a Catalent logo of a pharmaceutical company is seen ... [+] on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images ...